Allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for patients with inherited non-malignant diseases

被引：0
|
作者：
Borovkova, A. [1 ]
Bykova, T. [1 ]
Paina, O. [1 ]
Kozhokar, P. [1 ]
Slesarchuk, O.
Osipova, A.
Muhinova, A. [1 ]
Babenko, E. [1 ]
Barhatov, I. [1 ]
Ekushov, K. [1 ]
Averyanova, M.
Alyanskiy, A.
Semenova, E.
Zubarovskaya, L.
Afanasyev, B. [1 ]
机构：
[1] First I Pavlov State Med Univ St Petersburg, Raisa Gorbacheva Mem Res Inst Pediat Oncol Hemato, St Petersburg, Russia
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P587
引用
收藏
页码：S430 / S431
页数：2
相关论文
共 50 条
  • [21] Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide
    Nakamae, Hirohisa
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (04) : 465 - 481
  • [22] Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide
    Hirohisa Nakamae
    International Journal of Hematology, 2022, 116 : 465 - 481
  • [23] Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide
    Huntley, Dixie
    Gimenez, Estela
    Jesus Pascual, Maria
    Carlos Hernandez-Boluda, Juan
    Gago, Beatriz
    Vazquez, Lourdes
    Luis Pinana, Jose
    Garcia, Magdalena
    Perez, Ariadna
    Serrano, David
    Hernandez, Marta
    Albert, Eliseo
    Solano, Carlos
    Navarro, David
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (01)
  • [24] Optimizing the Dosing of Post-Transplantation Cyclophosphamide in a Murine Haploidentical Allogeneic Hematopoietic Cell Transplantation Model
    Wachsmuth, Lucas P.
    Castro, Ehydel
    Gress, Ronald E.
    Kanakry, Christopher G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S328 - S328
  • [25] Treosulfan-based conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases
    Jin Kyung Suh
    Ho Joon Im
    Sung Han Kang
    Hyery Kim
    Eun Seok Choi
    Kyung-Nam Koh
    Bone Marrow Transplantation, 2022, 57 : 681 - 684
  • [26] Treosulfan-based conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases
    Suh, Jin Kyung
    Im, Ho Joon
    Kang, Sung Han
    Kim, Hyery
    Choi, Eun Seok
    Koh, Kyung-Nam
    BONE MARROW TRANSPLANTATION, 2022, 57 (04) : 681 - 684
  • [27] Comparable outcomes of haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide and unrelated donor transplantation
    Hong, K. T.
    Kang, H. J.
    Choi, J. Y.
    Hong, C. R.
    Park, K. D.
    Shin, H. Y.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S484 - S484
  • [28] Health Care Utilization and Cost of Allogeneic Hematopoietic Cell Transplantation in Children with Malignant and Non-Malignant Diseases
    Ricci, Angela
    Jin, Zhezhen
    Bourgeois, Wallace
    Hall, Matt
    Satwani, Prakash
    BLOOD, 2017, 130
  • [29] Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
    Fernandes, Juliana Folloni
    Nichele, Samantha
    Arcuri, Leonardo Javier
    Ribeiro, Lisandro
    Zamperlini-Netto, Gabriele
    Loth, Gisele
    Melo Rodrigues, Ana Luiza
    Kuwahara, Cilmara
    Koliski, Adriana
    Trennepohl, Joanna
    Garcia, Julia Lopes
    Daudt, Liane Esteves
    Seber, Adriana
    Gomes, Alessandra Araujo
    Fasth, Anders
    Pasquini, Ricardo
    Hamerschlak, Nelson
    Rocha, Vanderson
    Bonfim, Carmem
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (10) : 1923 - 1929
  • [30] Chimerism after allogeneic stem cell transplantation in patients with non-malignant disorders
    Svenberg, P.
    Mattsson, J.
    Ringden, O.
    Uzunel, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S175 - S175
12345